The Effects of pH and PEG 400–Water Cosolvents on Oxytetracycline–Magnesium Complex Formation and Stability

REFERENCES

• Jones J. G., Morrison G. A. The bacteriostatic actions of tetracycline and oxytetracycline. J. Pharm. Pharmacol., June 1962; 808–824
   Google Scholar
• Albert A., Rees C. W. Avidity of the tetracyclines for the cations of metals. Nature March, 1956; 433
   PubMedGoogle Scholar
• Leeson L. J., Krueger J. E., Nash R. A. Concerning the structural assignment of the second and third acidity constants of the tetracycline antibiotics. Tetrahedron Lett. 1963; 18: 1155–1160
   Google Scholar
• Stephens C. R., Conover L. H., Gordon P. N., Pennington F. C, Wagner R. L., Brunings K. J., Pilgrim F. J. Epitetracycline—The chemical relationship between tetracycline and “Quatrimycin”. J. Am. Chem. Soc. 1956; 78: 1515–1516
   Web of Science ®Google Scholar
• Ibsen K. H., Urist M. R. Complexes of calcium and magnesium with oxytetracycline. Proc. Soc. Exp. Biol. Med. 1962; 109: 797–801
   PubMed Web of Science ®Google Scholar
• Dolusio J. T., Martin A. N. Metal complexation of the tetracycline hydrochlorides. J. Med. Chem. 1963; 6: 16–20
   PubMedGoogle Scholar
• Riaz M., Pilpel N. Complexation of tetracyclines with metal ions in relation to photosensitization. J. Pharm. Pharmacol. 1984; 36: 153–156
   PubMedGoogle Scholar
• Regna P. P., Solomons I. A., Murai K., Timeck A. E., Brunings K. J., Lazier W. A. The isolation and general properties of terramycin and terramycin salts. J. Am. Chem. Soc. 1951; 73: 4211–4215
   Google Scholar
• Sakaguchi T., Toma M., Yoshida T., Omura H., Takasu H. Metal chelate compounds with tetracycline derivatives, VII. The structure of tetracycline chelates. Chem. Pharm. Bull. (Tokyo) 1958; 1: 1–9
   Google Scholar
• Newman E. C., Frank C. W. Circular dichroism spectra of tetracycline complexes with Mg+2 and Ca+2. J. Pharm. Sci. 1976; 65(12)1728–1732
   PubMedGoogle Scholar
• Mitscher L. A., Slater-Eng B., Sokoloski T. D. Circular dichroism measurements of the tetracyclines IV. 5-Hydroxylated derivatives. Antimicrob. Agents Chemother. 1972; 2(2)66–72
   PubMedGoogle Scholar
• Mitscher L. A., Bonacci A. C., Slater-Eng B., Hacker A. K., Sokoloski T. D. Interaction of various tetracyclines with metallic cations in aqueous solutions as measured by circular dichroism. Antimicrob. Agents Chemother. 1970; 111–115
   Google Scholar
• Mitscher L. A., Bonacci A. C., Sokoloski T. D. Circular dichroism and solution conformation of the tetracycline antibiotics. Antimicrob. Agents Chemother. 1969; 78–86
   PubMedGoogle Scholar
• Chin T. F., Lach J. L. Drug diffusion and bioavailability: Tetracycline metallic chelation. Am. J. Hosp. Pharm. 1975; 32: 625–629
   PubMedGoogle Scholar
• Connors K. A., Amidon G. L., Stella V. L. Chemical Stability of Pharmaceuticals; A Handbook for Pharmacists. 2nd. Ed., John-Wiley & Sons, New York 1986
   Google Scholar
• Doerschuk A. P., Bitler B. A., McCormick J. R. D. Reversible isomerizations in the tetracycline family. J. Am. Chem. Soc. 1955; 77: 4687
   Web of Science ®Google Scholar
• McCormick J. R. D., Fox S. M., Smith L. L., Bitler B. A., Reichenthal J., Origoni V. E., Muller W. H., Winterbottom R., Doerschuk A. P. On the nature of the reversible isomerization occurring in the tetracycline family. J. Am. Chem. Soc. 1956; 78: 3547–3548
   Web of Science ®Google Scholar
• McCormick J. R. D., Fox S. M., Smith L. L., Bitler B. A., Reichenthal J., Origoni V. E., Muller W. H., Winterbottom R., Doerschuk A. P. The preparation, properties and proof of structure of some 4-epi-tetracyclines. J. Am. Chem. Soc. 1957; 79: 2849–2858, Studies of the reversible epimerization occurring in the tetracycline family
   Google Scholar
• Hussar D. A., Niebergall P. J., Sugita E. T., Doluisio J. T. Aspects of the epimerization of certain tetracycline derivatives. J. Pharm. Pharmacol. 1968; 20(7)539–546
   PubMedGoogle Scholar
• Izer K., Torok I., Pinter-Magyar P. Stability of oxytetracycline hydrochloride in eye-drops, prepared in pharmacies. Acta Pharm. Hung. 1994; 64: 63–66
   PubMedGoogle Scholar
• Vej-Hansen B., Bungaard H., Kreilgard B. Kinetics of degradation of oxytetracycline in aqueous solution. Arch. Pharm. Chem. Sci. Ed. 1978; 6: 151–163
   Google Scholar
• Cornwell R. L. Evaluation of a long-acting injectable oxytetracycline. Mod. Vet. Pract. 1980; 61: 945–947
   PubMedGoogle Scholar
• Hochstein F. A., Stephens C. R., Conover L. H., Regna P. P., Pasternack R., Gordon P. N., Pilgrim F. J., Brunings K. J., Woodward R. B. The structure of terramycin. J. Am. Chem. Soc. 1953; 75: 5455–5475
   Web of Science ®Google Scholar
• Chas. Pfizer and Co., Inc., Brit. Patent, 742,156, Dec. 21, 1955
   Google Scholar
• Ali S. L. K. FloryTetracycline hydrochloride. Analytical Profile of Drug Substances, . Academic Press, Inc., New York 1984; 13: 579–653
   Google Scholar
• Weinstein H. J., Lidsky S., Delahunt C. S. Preconstituted oxytetracycline intramuscular solution, a new preparation. Antibiot. Med. Clin. Ther. 1959; 6: 526–533
   PubMedGoogle Scholar
• Aguiar A. J., Armstrong W. W., Desai S. J. Development of oxytetracycline long-acting injectable. J. Controlled Release 1987; 6: 375–385
   Google Scholar
• Sanniez W. H. K., Pilpel N. Photodecomposition of sulfonamides and tetracyclines at oil-water interfaces. J. Pharm. Sci. 1980; 69(1)5–8
   PubMedGoogle Scholar
• Weibe J. A., Moore D. E. Oxidation photosensitized by tetracyclines. J. Pharm. Sci. 1977; 66: 186
   PubMedGoogle Scholar
• Katz M., Klioze O., P'an S. Y. A study of parenteral oxytetracycline and tetracycline. J. Am. Pharm. Assoc. 1955; 44(12)751–755
   Google Scholar
• Job P. Recherches sur la formation de complexes mineraux en solution et sur leur stabilité. Ann. Chim 1928; 9: 113–134
   Google Scholar
• Barnes W. N., Ray A., Bates L. J. Reversed-phase high performance liquid chromatographic method for the assay of oxytetracycline. J. Chromatogr. 1985; 347(1)173–178
   PubMedGoogle Scholar
• Mitscher L. A. The Chemistry of the Tetracycline Antibiotics. Marcel Dekker Inc., New York and Basel 1979
   Google Scholar
• Sina A., Youssef M. K., Kassem A. A., Attia I. A. Stability of oxytetracycline in solutions and injections. Can. J. Pharm. Sci. 1974; 9(2)9
   Google Scholar
• Ikeda K., Tomida H., Yotsuyanagi T. Micellar interaction of tetracycline antibiotics. Chem. Pharm. Bull. (Tokyo) 1977; 25(5)1067–1072
   PubMedGoogle Scholar
• Barringer W. C., Shultz W., Sieger G. M., Nash R. A. Minocycline hydrochloride and its relationship to other tetracycline antibiotics. Am. J. Pharm. Nov–Dec, 1974; 179–191
   Google Scholar
• Bailey F. E., Jr., Koleske J. V. Alkylene Oxides and Their Polymers. Mercer Dekker, Inc., New York 1991; 35: 153–166
   Google Scholar
• Harris J. M. Poly(ethylene Glycol) Chemistry: Biotechnical and Biomedical Applications. Plenum Press, New York 1992; 1–13
   Google Scholar
• Harris J. M., Hundley N. H., Shannon T. G., Struck E. C. L. Mathias, C. E. CarreherCrown Ethers and Phase Transfer Catalysis in Polymer Science, . Plenum Press, New York 1984; 371
   Google Scholar
• Tongaree S., Flanagan D. R., Poust R. I. The interaction between oxytetracycline and divalent metal ions in aqueous and mixed solvent systems. Pharm. Dev. Technol. 1999; 4(4)581–591
   PubMed Web of Science ®Google Scholar